000148372 001__ 148372
000148372 005__ 20240229112702.0
000148372 0247_ $$2doi$$a10.1016/S1470-2045(19)30669-2
000148372 0247_ $$2pmid$$apmid:31797797
000148372 0247_ $$2ISSN$$a1470-2045
000148372 0247_ $$2ISSN$$a1474-5488
000148372 0247_ $$2altmetric$$aaltmetric:71697760
000148372 037__ $$aDKFZ-2019-02928
000148372 041__ $$aeng
000148372 082__ $$a610
000148372 1001_ $$aFranceschi, Enrico$$b0
000148372 245__ $$aEANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma.
000148372 260__ $$aLondon$$bThe Lancet Publ. Group$$c2019
000148372 3367_ $$2DRIVER$$aarticle
000148372 3367_ $$2DataCite$$aOutput Types/Journal article
000148372 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1575894207_21053$$xReview Article
000148372 3367_ $$2BibTeX$$aARTICLE
000148372 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000148372 3367_ $$00$$2EndNote$$aJournal Article
000148372 520__ $$aThe European Association of Neuro-Oncology (EANO) and EUropean RAre CANcer (EURACAN) guideline provides recommendations for the diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma. The guideline is based on the 2016 WHO classification of tumours of the CNS and on scientific developments published since 1980. It aims to provide direction for diagnostic and management decisions, and for limiting unnecessary treatments and cost. In view of the scarcity of data in adults with medulloblastoma, we base our recommendations on adult data when possible, but also include recommendations derived from paediatric data if justified. Our recommendations are a resource for professionals involved in the management of post-pubertal and adult patients with medulloblastoma, for patients and caregivers, and for health-care providers in Europe. The implementation of this guideline requires multidisciplinary structures of care, and defined processes of diagnosis and treatment.
000148372 536__ $$0G:(DE-HGF)POF3-312$$a312 - Functional and structural genomics (POF3-312)$$cPOF3-312$$fPOF III$$x0
000148372 588__ $$aDataset connected to CrossRef, PubMed,
000148372 7001_ $$aHofer, Silvia$$b1
000148372 7001_ $$aBrandes, Alba A$$b2
000148372 7001_ $$aFrappaz, Didier$$b3
000148372 7001_ $$aKortmann, Rolf-Dieter$$b4
000148372 7001_ $$aBromberg, Jacoline$$b5
000148372 7001_ $$aDangouloff-Ros, Volodia$$b6
000148372 7001_ $$aBoddaert, Nathalie$$b7
000148372 7001_ $$aHattingen, Elke$$b8
000148372 7001_ $$aWiestler, Benedikt$$b9
000148372 7001_ $$aClifford, Steven C$$b10
000148372 7001_ $$aFigarella-Branger, Dominique$$b11
000148372 7001_ $$aGiangaspero, Felice$$b12
000148372 7001_ $$aHaberler, Christine$$b13
000148372 7001_ $$aPietsch, Torsten$$b14
000148372 7001_ $$0P:(DE-He78)a7c1bbac024fa232d9c6b78443328d9d$$aPajtler, Kristian W$$b15$$udkfz
000148372 7001_ $$0P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9$$aPfister, Stefan M$$b16$$udkfz
000148372 7001_ $$aGuzman, Raphael$$b17
000148372 7001_ $$aStummer, Walter$$b18
000148372 7001_ $$aCombs, Stephanie E$$b19
000148372 7001_ $$aSeidel, Clemens$$b20
000148372 7001_ $$aBeier, Dagmar$$b21
000148372 7001_ $$aMcCabe, Martin G$$b22
000148372 7001_ $$aGrotzer, Michael$$b23
000148372 7001_ $$aLaigle-Donadey, Florence$$b24
000148372 7001_ $$aStücklin, Ana S Guerreiro$$b25
000148372 7001_ $$aIdbaih, Ahmed$$b26
000148372 7001_ $$aPreusser, Matthias$$b27
000148372 7001_ $$avan den Bent, Martin$$b28
000148372 7001_ $$aWeller, Michael$$b29
000148372 7001_ $$aHau, Peter$$b30
000148372 773__ $$0PERI:(DE-600)2035574-9$$a10.1016/S1470-2045(19)30669-2$$gVol. 20, no. 12, p. e715 - e728$$n12$$pe715 - e728$$tThe lancet <London> / Oncology Oncology$$v20$$x1470-2045$$y2019
000148372 909CO $$ooai:inrepo02.dkfz.de:148372$$pVDB
000148372 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a7c1bbac024fa232d9c6b78443328d9d$$aDeutsches Krebsforschungszentrum$$b15$$kDKFZ
000148372 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9$$aDeutsches Krebsforschungszentrum$$b16$$kDKFZ
000148372 9131_ $$0G:(DE-HGF)POF3-312$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunctional and structural genomics$$x0
000148372 9141_ $$y2019
000148372 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000148372 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000148372 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000148372 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bLANCET ONCOL : 2017
000148372 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000148372 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000148372 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000148372 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000148372 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000148372 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000148372 915__ $$0StatID:(DE-HGF)9930$$2StatID$$aIF >= 30$$bLANCET ONCOL : 2017
000148372 9201_ $$0I:(DE-He78)B062-20160331$$kB062$$lPädiatrische Neuroonkologie$$x0
000148372 9201_ $$0I:(DE-He78)L101-20160331$$kL101$$lDKTK Heidelberg$$x1
000148372 980__ $$ajournal
000148372 980__ $$aVDB
000148372 980__ $$aI:(DE-He78)B062-20160331
000148372 980__ $$aI:(DE-He78)L101-20160331
000148372 980__ $$aUNRESTRICTED